Resultados de la ablación por radiofrecuencia en el tratamiento de carcinoma hepatocelular en Veracruz, México
Cirujano General · 2021
DOI: 10.35366/103910 ↗At a glance
Journal article in Cirujano General, 2021. Written by Alonso Heriberto Ramírez-Sánchez and 4 co-authors. 23 references.
Abstract (original language)
Introduction
Hepatocellular carcinoma (HCC) is the most frequent malignant primary liver tumor. Only 15% of patients will undergo surgical resection or transplantation, thus local ablation is an important treatment with many advantages.
Objective
To evaluate the effectiveness of radiofrequency ablation in our population. Material and methods: Retrospective study of patients with hepatocellular carcinoma undergoing radiofrequency ablation, analyzing sociodemographic variables, tumor relate, stage (Child-Pugh, OKUDA, BCLC, CLIP, MELD and ALBI), use of sorafenib and survival.
Results
Sixteen patients (average age 71.25 years) with concomitant pathology in 87.5%, were analyzed. 62.5% of the patients suffered cirrhosis, 56.3% Child-Pugh A and 6.3% B. 62.5% of patients were OKUDA I. 37.5% with BCLC A, 56.3% BCLC B and 6.3% BCLC C. 56.3% were CLIP 0. Average MELD 8.44 ± 2.15 and average ALBI -2.54 ± 0.42. Tumor size was 5.81 ± 2.81 cm and use of sorafenib in 25%. Average survival was 37.76 months, survival rate 58.5% at one year and 23.4% at five. Low body mass index was associated with low survival (p = 0.031).
Conclusion
Our study indicates that radiofrequency ablation is used in patients with hepatocellular carcinoma in various stages and sometimes in tumors > 5 cm, making survival shorter than other studies.
Cite
APA
Ramírez-Sánchez, A. H., Casanova-Sánchez, I. E., Esquivel-Torres, S., Escobar-Ríos, A. Y., & Martínez-Mier, G. (2021). Resultados de la ablación por radiofrecuencia en el tratamiento de carcinoma hepatocelular en Veracruz, México. Cirujano General. https://doi.org/10.35366/103910
Vancouver
Ramírez-Sánchez AH, Casanova-Sánchez IE, Esquivel-Torres S, Escobar-Ríos AY, Martínez-Mier G. Resultados de la ablación por radiofrecuencia en el tratamiento de carcinoma hepatocelular en Veracruz, México. Cirujano General. 2021. doi:10.35366/103910
BibTeX
@article{RamrezSnchez2021,
author = {Ramírez-Sánchez, Alonso Heriberto and Casanova-Sánchez, Iván Eliud and Esquivel-Torres, Sergio and Escobar-Ríos, Alma Yrani and Martínez-Mier, Gustavo},
title = {Resultados de la ablación por radiofrecuencia en el tratamiento de carcinoma hepatocelular en Veracruz, México},
journal = {Cirujano General},
year = {2021},
doi = {10.35366/103910}
}
EUVIMED